RE:RE:RE:RE:RE:RE:PanCan's Precision Promise adaptive clinical trial programThe ball is starting to roll. The shorts better start to cover or pay big time.
A $5 million grant? Not huge $$ BUT HUGE afirmation of the opportunity to move Pela forward.
About a month agao there was an institutional buy-in for $17 million.
Now $5 million from a grant.
These are larger outsiders doing a lot of due dilligence.
I expect yet another N.R. tomorrow am, before the fireside chat.
No idea what. So far this month has been full of surprises.
All of them good!
I did see a report a few days ago, the short trading was 62% that is veryhigh.
Could explain the dip & then recovery today.
PanCan are no fools. They have just came up to the table with $5million to add another opportunity.
MY read...no partnership.
Total buy-out, once phase 3 is underway.